The Researchers are trying to determine the paths of change in imaging biomarkers of Dementia with Lewy bodies (DLB) and their associations with rate of cognitive and functional decline.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Rate of change in 18F-Flortaucipir PET imaging and Pittsburgh compound-B PET imaging
Timeframe: Will be assessed 3 times annually over at least three years